---

$15.91

-0.0100 ( -0.06% ) 0.0K

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to better meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2024-08-09	Buy	999800.00	Samaha Eli
2024-08-09	Sale	-3252.00	Winningham Rick E
2024-07-12	Sale	-4000.00	Farnum Rhonda
2024-05-22	Sale	-8635.00	Sawaf Aziz
2024-05-22	Sale	-9268.00	Grimaud Brett A.
2024-05-22	Sale	-15997.00	Winningham Rick E
2024-05-22	Sale	-9268.00	Farnum Rhonda
2024-05-22	Sale	-5201.00	Miller Aine
2024-05-17	Sale	-2068.00	Winningham Rick E
2024-05-10	Sale	-10537.00	Smaldone Alsup Laurie